Symposium EN-01 (UG)
Nov. 16 (Fri) 08:30-10:00	Minimal invasive therapy of early gastric cancer: from ESD to surgery	101 (1F)
Chairperson(s)	Hyung-Ho Kim (Seongnam), Takuji Gotoda (Tokyo)
08:30-08:50	How to choose a patient with early gastric cancer who can be treated with endoscopic submucosal dissection	Ning Bo/ Enqiang Linghu (Beijing)
08:50-09:10	ESD for early gastric cancer with undifferentiated histology: do we have enough data?	Takuji Gotoda (Tokyo)
09:10-09:30	Risk stratification of noncurative ESD: do all patient need additional treatment?	Jun Chul Park (Seoul)
09:30-09:50	Sentinel node navigation surgery for early gastric cancer: when and how to perform?	Masanori Terashima (Nagaizumi)
09:50-10:00	Q&As

Symposium EN-02 (LG)
Nov. 16 (Fri) 08:30-10:00	Progress in the detection and management of colorectal neoplasm	102 (1F)
Chairperson(s)	Hermann Brenner (Heidelberg), Han-Mo Chiu (Taipei)
08:30-08:50	Image enhanced endoscopy in colorectal cancer screening: current status	Wai Keung Leung (Hong Kong)
08:50-09:10	Computer-aided detection and histopathology prediction for colorectal polyps	Jeong-Sik Byeon (Seoul)
09:10-09:30	Detection and removal of serrated lesions	Hyo-Joon Yang (Seoul)
09:30-09:50	Recent advances in colorectal ESD	Takahisa Matsuda (Tokyo)
09:50-10:00	Q&As

Symposium LV-01
Nov. 16 (Fri) 08:30-10:00	Chronic hepatitis B: current medication	103 (1F)
Chairperson(s)	Seung Kew Yoon (Seoul), George Lau (Hong Kong)
08:30-08:50	Can we stop the neucleot(s)ide analogue?	George Lau (Hong Kong)
08:50-09:10	Prevention of new HBV infection: nucleotide analogue in pregnant women and vaccination	Henry LY Chan (Hong Kong)
09:10-09:30	HBV and HCV coinfection	Jidong Jia (Beijing)
09:30-09:50	Bepatitis B prophylaxis and occult hepatitis B in immunocompromized patients: to whom and how long	Seng Gee Lim (Singapore)
09:50-10:00	Q&As

Symposium PB-01
Nov. 16 (Fri) 08:30-10:00	New insights in the biliary system	104 (1F)
Chairperson(s)	D. Nageshwar Reddy (Hyderabad), Ho Soon Choi (Seoul), Shutian Zhang (Beijing)
08:30-08:50	Optimal evaluation of premalignant biliary lesions	Seon Mee Park (Cheongju)
08:50-09:10	Optimal approach to the indeterminate bile duct stricture	Hsiu-Po Wang (Taipei)
09:10-09:30	Updates on difficult biliary stones management	Chang-Il Kwon (Seongnam)
09:30-09:50	Best Endoscopic drainage of biliary system	Shutian Zhang (Beijing)
09:50-10:00	Q&As

Symposium GI-01 (Motility)
Nov. 16 (Fri) 08:30-10:00	Updates in gastrointestinal neurogastro-motility disorders	105 (1F)
Chairperson(s)	Nicholas J Talley (Newcastle), Kwang Jae Lee (Suwon)
08:30-08:50	Approach to esophageal disorders	John Pandolfino (Wilmette)
08:50-09:10	Approach to gastric disorders	Nicholas J Talley (Newcastle)
09:10-09:30	Approach to bowel disorders	Eamonn Quigley (Houston)
09:30-09:50	Differences of guidelines between Asia and West	Jung-Ho Park (Seoul)
09:50-10:00	Q&As

SIDDS 1
Nov. 16 (Fri) 08:30-10:00	Understanding of molecular alteration: the cornerstone for treatment of GI cancer	202 (2F)
Chairperson(s)	James R. Goldenring (Nashville), Seung Woo Park (Seoul)
08:30-08:55	The mechanisms responsible for the development of pre-neoplastic lineages from metaplasias in the stomach and their roles in gastric carcinogenesis	James R. Goldenring (Nashville)
08:55-09:20	Proteomic Multi-Marker Panel for Early Detection of GI cancers Using Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS)	Youngsoo Kim (Seoul)
09:20-09:45	Control of GI cancer using CRIPR-Cas9	Hyongbum Kim (Seoul)
09:40-10:00	Q&As

Symposium EN-03 (UG)
Nov. 16 (Fri) 08:30-10:00	Recent update in treatment for GI subepithelial tumors	203 (2F)
Chairperson(s)	Hoon Jai Chun (Seoul), Seigo Kitano (Oita)
08:30-08:50	Resection for subepithelial tumors: when is it needed?	Jie-Hyun Kim (Seoul)
08:50-09:10	Endoscopic resection of subepithelial tumors via standard EMR/ESD technique	Kyoung Oh Kim (Inchoen)
09:10-09:30	Endoscopic full thickness resection of subepithelial tumors	Chan Gyoo Kim (Goyang)
09:30-09:50	Minimally invasive surgery for subepithelial tumors	Osamu Goto (Tokyo)
09:50-10:00	Q&As

E-poster Presentation-01 (UG, Motility)
Nov. 16 (Fri) 08:30-10:00	Esophagus	R1A (3F)
Chairperson(s)	Jung-Ho Park (Seoul), William Tam (Adelaide)
08:30-08:36	Utility of adjunctive rapid drink test (RDT) during high resolution esophageal manometry (HREM) in sitting position for evaluating functional esophagogastric junction outflow obstruction (EGJOO)	Tanisa Patcharatrakul (Bangkok)
08:36-08:42	Reduction of proton pump inhibitor (PPI) usage in patients with gastroesophageal reflux disease (GERD) after undergoing stretta procedure, an east malaysia perspective.	Phei Oon Tan (Kota Kinabalu)
08:42-08:48	The relationship between hypomotility disorders, hypotensive lower esophageal sphincter and gastroesophageal reflux diseases symptoms.	Hang Dao (Hanoi)
08:48-08:54	Taking the next steps in endoscopic visual assessment of barretts esophagus	Roxana Chis (Kingston)
08:54-09:00	Do we need to exclude epigastric symptoms for GERD diagnosis?	Mengyu Zhang (Guangzhou)
09:00-09:06	Effect of anti-reflux mucosectomy (ARMS) for refractory GERD underwent 24-hour pH-impedance (MII-pH) off PPI before and after ARMS	Kazuya Sumi (Tokyo)
09:06-09:12	Immunohistochemical expression of transient receptor vanilloid 4 (TRPV4), a marker of visceral hypersensitivity in NERD and controls	Mung Seong Wong (Kota Bharu)
09:12-09:18	Normative values for 24-hours ambulatory multichannel intraluminal impedance and pH monitoring (sandhill and MMS systems) in the malay population	Su Fui Thung (Kota Bharu)
09:18-09:24	Normative Chicago 3.0 metrics for high-resolution esophageal manometry (sandhill and MMS systems) in the malay population and the effects of boluses types and postures on normative Metrics	Su Fui Thung (Kota Bharu)
09:24-09:30	Effects of provocative bolus and positions on chicago 3.0 metrics in normal malay population.	Su Fui Thung (Kota Bharu)
09:30-09:36	Clinical characteristics of untreated achalasia patients in Taiwan: a prospective study based on high-resolution impedance manometry	Ping-Huei Tseng (Taipei)
09:36-09:42	Prevalence and risk factors of Barrett's esophagus in Vietnamese patients with upper gastrointestinal symptoms	Quyen Thi Trieu Pham (Ho Chi Minh)
09:42-09:48	The endoscopic and clinicopathological characteristics of Barrett's esophagus in Vietnamese patients	Truc Le Thanh Tran (Ho Chi Minh)
09:48-09:54	Pneumatic dilation, more than a treatment of achalasia - evaluation of compliance of esophagogastric junction by pneumatic dilation balloon before POEM	Hailong Cao (Tianjin)

E-poster Presentations-02 (LG)
Nov. 16 (Fri) 08:30-10:00	Inflammatory bowel disease (1)	R1C (3F)
Chairperson(s)	Tae Oh Kim (Busan), Chang Hwan Choi (Seoul)
08:30-08:36	Do patients, their families, and doctors really think the same? A population-based, multi-centered cohort study using the inflammatory bowel disease disability index	Jun Shen (Shanghai)
08:36-08:42	Using magnetic resonance imaging to evaluate the effectiveness in perianal fistulising Crohns disease	Jun Shen (Shanghai)
08:42-08:48	Distinct cutoff values of adalimumab trough levels are associated with different therapeutic outcomes in patients with inflammatory bowel disease	Sang Hyoung Park (Seoul)
08:48-08:54	Endoscopic diagnosis of non-pedunculated dysplasia during surveillance in the ulcerative colitis: a survey-based, multinational studies	Dong-Hoon Yang (Seoul)
08:54-09:00	Infliximab trough levels are associated with transmural healing during maintenance treatment in pediatric Crohn's disease patients	Ben Kang (Daegu)
09:00-09:06	Impact of superimposed cytomegalovirus infection on the outcomes of ulcerative colitis flare-up	Shin Ju Oh (Seoul)
09:06-09:12	Histone H3 acetylation protects ulcerative colitis by inhibiting NF-B/p65 and enhancing intestinal epithelial barrier function	Chunxiao Li (Hangzhou)
09:12-09:18	Helicobacter pylori infection in inflammatory bowel disease: protective or harmful?	Yang Yu (Beijing)
09:18-09:24	The Efficacy and safety of adalimumab for the patients with moderate to severely active ulcerative colitis and predictors of response in Korea (EUREKA): preliminary results	Chang Hwan Choi (Seoul)
09:24-09:30	Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring	Sung-Shuo Kao (Kaohsiung)
09:30-09:36	Doctors perspectives on the use of traditional, complementary and alternative medicine in inflammatory bowel disease: the first doctors report in Asia	Jessica Y L Ching (Hong Kong)

E-poster Presentations-03 (LV)
Nov. 16 (Fri) 08:30-10:00	Acute hepatitis, viral hepatitis, liver failure, HCC	R2A (3F)
Chairperson(s)	Jong Young Choi (Seoul), Young Oh Kwon (Daegu)
08:30-08:36	Hormonal component of the pathogenesis of chronic liver disease	Saidrakhim Nodirovich Lukmonov (Tashkent)
08:36-08:42	Inflammatory cytokines and the change of Th1/Th2 balance as prognostic indicators for HCC in patients treated with transarterial chemoembolization	Hae Lim Lee (Bucheon)
08:42-08:48	Clinical characteristics of long term survivors following sorafenib treatment for unresectable hepatocellular carcinoma: Korean national multi-center retrospective cohort study	Young Youn Cho (Seoul)
08:48-08:54	Assessing HCV distribution among hard to reach populations in London using whole genome sequencing: report from the TB reach study	Dewi Nur Aisyah (Depok)
08:54-09:00	Modelling hepatitis C direct acting antiviral (DAA) treatment scale up among people who inject drugs in London: working towards WHO incidence elimination target by 2030	Dewi Nur Aisyah (Depok)
09:00-09:06	Evaluation of utility of predictive models for acute-on-chronic liver failure	Li Peng Margaret Teng (Singapore)
09:06-09:12	Early hepatitis is the strongest risk factor for the development of severe dengue infection: a points-based risk-score to predict critical disease in dengue fever	Madunil Anuk Niriella (Ragama)
09:12-09:18	Barriers to hepatocellular carcinoma (HCC) surveillance in at-risk individuals in Thailand	Palada Pitakkitnukun (Bangkok)
09:18-09:24	Temporal profile of HEV RNA concentration in blood and stool in patients with acute hepatitis E	Vijay Kumar Halkurike Jayadevappa (Lucknow)
09:24-09:30	miRNA-221-5p promotes epithelial-mesenchymal transition in hepatocellular carcinoma through regulation of CD44/TGF-beta1	Na Ri Park (Seoul)
09:30-09:36	Understanding recurrence related oncogenic kinases and metabolites in liver cancer	Hongping Xia (Singapore)

E-poster Presentations-04 (LG)
Nov. 16 (Fri) 08:30-10:00	Irritable bowel disease (IBS), microbiology	R2C (3F)
Chairperson(s)	Byung Ik Jang (Daegu), Shengtao Zhu (Beijing)
08:30-08:36	Maternal western-style diet alters gut microbiota of offspring and exacerbates intestinal inflammation in adulthood	Hailong Cao (Tianjin)
08:36-08:42	Profiles of bacteria-derived extracellular vesicles in stool, serum and urine in patients with colorectal cancer: a preliminary study	Jae Ho Cho (Seongnam)
08:42-08:48	Characteristics of mucosa-associated fungal microbiota during treatment in Crohn's disease	Cong He (Nanchang)
08:48-08:54	The impact of helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: an open-label, prospective clinical trial	Luyi Chen (Hangzhou)
08:54-09:00	Bloating and its association with functional gastrointestinal disorders according to ROME III diagnostic criteria	Kewin Tien Ho Siah (Singapore)
09:00-09:06	Transcriptome and methylome profiling in a rat model of irritable bowel syndrome induced by stress	Shengtao Zhu (Beijing)
09:06-09:12	Investigating the functional role of clostridium hathewayi in colorectal carcinogenesis	Thomas Kwong (Hong Kong)
09:12-09:18	The impact of veterinary antibiotic residue in foods on obesity and antibiotic resistance through modulation of gut microbiota	Wei-Kai Wu (Taipei)
09:18-09:24	Overlapping functional GI disorders (FGID) and new-onset constipation associated with more GI symptom severity in FGID patients during hospitalization	Tanisa Patcharatrakul (Bangkok)

PG Course-LV (Korean)
Nov. 16 (Fri) 08:30-10:00	Concerning points and management during treatment for liver disease	E1+2 (3F)
Chairperson(s)	So Young Kwon (Seoul), June Sung Lee (Goyang)
08:30-08:50	During antiviral therapy for HBV	Hyun Phil Shin (Seoul)
08:50-09:10	During antiviral therapy for HCV	In Hee Kim (Jeonju)
09:10-09:30	During imunosuppressive therapy for Autoimmune liver disease	Eun Ju Cho (Seoul)
09:30-09:50	During systemic therapy for HCC	Sung-Bum Cho (Gwangju)
09:50-10:00	Q&As

Free Paper (PB 1) (Korean)
Nov. 16 (Fri) 08:30-10:00	KDDW Free Paper (PB 01)	E3 (3F)
Chairperson(s)	Young Woo Choi (Daejeon), Kyu Taek Lee (Seoul)
08:30-08:40	Comparison of therapeutic efficacy and safety between standard-dose FOLFIRINOX and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer: a retrospective study	Huapyong Kang (Seoul)
08:40-08:50	Korean experiences with liposomal irinotecan for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy.	Juyeon Oh (Goyang)
08:50-09:00	Comparison of FOLFIRINOX and Gemcitabine with Nab-paclitaxel in Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer Registry (K-PAC)	Jong-Chan Lee (Seongnam)
09:00-09:10	Surveillance versus surgery for incidental, asymptomatic, small solid pseudopapillary neoplasm (SPN) of the pancreas	Joune Seup Lee (Seoul)
09:10-09:20	Efficacy of endobiliary radiofrequency ablation for malignant distal biliary obstruction: A propensity score matched multicenter study	Eui Joo Kim (Incheon)
Chairperson(s)	Seokho Dong (Seoul), Don Haeng Lee (Incheon)
09:20-09:30	The importance of elevated serum viscosity in pancreaticobiliary cancer patients	Hwang Seonyeong (Seoul)
09:30-09:40	Prognostic impact of minimal Pelvic Fluid in pancreatic cancer stage III	Young-Hwa Kim (Incheon)
09:40-09:50	Chromogranin A as a prognostic marker in pancreatic adenocarcinoma	Jung Hyun Jo (Seoul)
09:50-10:00	complementary role of Serum DUPAN-2 for screening of Carbohydrate Antigen 19-9 in patients with pancreatico-biliary malignancy	Jae Woo Kim (Wonju)

Free Paper (GI Cancer 1) (Korean)
Nov. 16 (Fri) 08:30-10:00	KDDW Free Paper (GI Cancer 01)	E4 (3F)
Chairperson(s)	Jin Tae Jung (Daegu), Su Youn Nam (Daegu)
08:30-08:40	Effects of a 12 week home-based exercise program in patients with high risk of gastric cancer: A pilot study	Jeung Eun Lee (Seoul)
08:40-08:50	Subepithelial spread of early gastric signet ring cell carcinoma: How far they can reach?	Sun Hyung Kang (Daejeon)
08:50-09:00	Gastric cancer with lymph node metastasis more than 15 (N3b): is it really stage III disease?	Sa-Hong Kim (Seoul)
09:00-09:10	Predictive factors of lymph node metastasis in early gastric cancer patients with Seiwert type II/III	Min Young Son (Busan)
09:10-09:20	Abdominal computed tomography compared with endoscopic ultrasound sonography for the diagnosis of gastric subepithelial tumors	Cheal Wung Huh (Incheon)
Chairperson(s)	Eun Kwang Choi (Jeju), Seung-Ok Lee (Jeonju)
09:30-09:40	Incidence and prognosis of subsequent cholangiocarcinoma in patients with hepatic resection for bile duct stones	Seon Mee Park (Cheongju)
09:40-09:50	Validation of the 8th edition of the American Joint Commission on Cancer (AJCC) staging system for pancreatic adenocarcinoma: Using Korean pancreatic cancer (K-PAC) registry	Dong Woo Shin (Seongnam)
09:50-10:00	Clinicopathologic characteristics of Intraductal Papillary Neoplasm of Bile duct (IPNB) after central review: Korean multi-center collaboration study	Jae Ri Kim (Seoul)
10:00-10:10	Adjuvant gemcitabine-based chemotherapy vs concurrent chemoradiotherapy after R0 resection for pancreatic ductal adenocarcinoma: A propensity score-matched analysis	Min Su You (Seoul)

Free Paper (LG 1) (Korean)
Nov. 16 (Fri) 08:30-10:00	KDDW Free Paper (LG 01)	E5 (3F)
Chairperson(s)	Kyu Chan Huh (Daejeon), Sung-Ae Jung (Seoul)
08:30-08:40	A trial for the administration of a functionally enhanced tonsil-derived mesenchymal stem cells in a chronic colitis model.	Yang Hee Joo (Seoul)
08:40-08:50	The ability of epithelial regeneration is reduced in the Crohn's disease patient-derived organoids, especially in TNF-alpha enriched condition.	Sung Noh Hong (Seoul)
08:50-09:00	Diagnostic role of NOD signaling and apoptosis tests in patients with XIAP-deficient IBD	Seak Hee Oh (Seoul)
09:00-09:10	Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers	Soo-Kyung Park (Seoul)
09:10-09:20	Identification of prominent hub genes of colorectal cancer : Using network analysis of gene expression data	Seong Ji Choi (Seoul)
Chairperson(s)	Byong Duk Ye (Seoul), Geom Seog Seo (Iksan)
09:20-09:30	Vegetarianism as a protective factor for asymptomatic colonic diverticulosis; A cross-sectional, case-control study between Buddhist priests and general population	Jihun Bong (Goyang)
09:30-09:40	Clinical outcome after endoscopic decompression of sigmoid volvulus; A multicenter-retrospective study, Daejeon-Chungchung intestinal research group	Hee Seok Moon (Daejeon)
09:40-09:50	Identification and validation of a peptide probe binding specifically to colon cancer cells	Younghee Choe (Seoul)

Mastering NBI
Nov. 16 (Fri) 08:50-11:40	Mastering NBI - Collaboration with ANBIIG	205 (2F)
Chairperson(s)	Rajvinder Singh (Adelaide), Bo-In Lee (Seoul)
08:50 - 09:10	NBI in the Oesophagus: Current and best practice, 2018	Rajvinder Singh (Adelaide)
09:10 - 09:25	Case discussion: esophagus	Jung-Wook Kim (Seoul)
09:25 - 09:45	NBI detection and characterization of stomach cancers	Mitsuhiro Fujishiro (Tokyo)
09:45 - 10:00	Case discussion: stomach	Jun-Hyung Cho (Seoul)
10:30 - 10:50	NBI detection and characterization of colorectal polyps	Nozomu Kobayashi (Tochigi)
10:50 - 11:05	Case discussion: colon, histologic prediction	Han Hee Lee (Seoul)
11:05 - 11:25	Estimation of invasion depth in colorectal lesions	David Hewett (Brisbane)
11:25 - 11:40	Case discussion: estimation of invasion depth	Yunho Jung (Cheonan)

Free Paper (LG 2) (Korean & English)
Nov. 16 (Fri) 10:20-11:10	KDDW Free Paper (LG 02)	E5 (3F)
Chairperson(s)	Jin-Oh Kim (Seoul), Chang Hwan Choi (Seoul)
10:20-10:30	Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin	Kyung Mo Yoo (Seoul)
10:30-10:40	Clinicopathological features of malignant tumors of small bowel diagnosed by video capsule endoscopy and balloon-assisted enteroscopy: A single center experience	Sunghee Kam (Seoul)
10:40-10:50	Modifiable lifestyle risk factors and the risk of colorectal neoplasia recurrence	Kyungjin Ko (Seoul)
10:50-11:00	Differences in the clinicopathologic characteristics between right- and left-sided colon cancer	Hannah Ra (Incheon)
11:00-11:10	Epidemiology of colorectal cancer in Northern Malaysia: A 7-year review (2008-2014)	Mohamad Fadli Abd Rahman (Alor Setar)

SIDDS 2
Nov. 16 (Fri) 10:30-12:00	Host-microbiome interactions in Gut and Liver disease	202 (2F)
Chairperson(s)	Takanori Kanai (Tokyo), Jin-Wook Kim (Seongnam)
10:30-10:50	Understanding human gut microbiome and diseases	Jongsik Chun (Seoul)
10:50-11:10	The innate immune capacity of macrophages in regulation of intestinal barrier function and inflammation	Eunok Im (Busan)
11:10-11:30	T cells and immunoregulatory cytokines in intestinal inflammation: implication on IBD treatment	Takanori Kanai (Tokyo)
11:30-11:50	Gut-liver axis in Liver diseases	Ki Tae Suk (Chuncheon)
11:50-12:00	Q&As

Plenary 2 (UG, LG, Motility)
Nov. 16 (Fri) 10:30-12:00	KDDW Plenary 2 (UG, LG, Motility)	203 (2F)
Chairperson(s)	Yong Chan Lee (Seoul), Tae Il Kim (Seoul), In Kyung Sung (Seoul)
10:30-10:45	Trough levels of infliximab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on infliximab maintenance therapy	Eun Hye Oh (Seoul)
10:45-11:00	Link between symptom severity, gender and self-reported psychiatric disorders in patients with organic and functional gastrointestinal disorders: A prospective cohort study in 12,806 consecutive patients referred for specialist treatment at a tertiary cen	Ayesha Shah (Brisbane)
11:00-11:15	utility of measurement EGJ distensibility in patients with achalasia	Junsu Chang (Sungnam)
11:15-11:30	Transient Receptor Vanilloid 4 (TRPV4), a Marker of Visceral Hypersensitivity is present in NERD and Controls	Nazihah Azis (Kota Bharu)
11:30-11:45	Metachronous recurrence of gastric epithelial neoplasia according to Helicobacter pylori infection and microsatellite state : Long term follow-up results and clinical outcome	Jaeyoung Kim (Suwon)
11:45-12:00	Association between family history of colorectal cancer and the risk of metachronous colorectal neoplasia following polypectomy in patients aged <50 years	Hyun Beom Chae (Seoul)

PG Course-Endoscopy (Korean)
Nov. 16 (Fri) 10:30-12:00	Basic drainage technique of Pancreatobiliary diseases (PG course)	E1+2 (3F)
Chairperson(s)	Sang-Heum Park (Cheonan), Dae Hwan Kang (Yangsan)
10:30-10:50	Biliary drainage: benign and malignant distal biliary obstruction	Dong-Won Ahn (Seoul)
10:50-11:10	Biliary drainage: advanced hilar obstruction	Tae Hoon Lee (Cheonan)
11:10-11:30	Obstructed pancreatic duct drainage: transpapillary and EUS-guided drainage	Se Woo Park (Hwaseong)
11:30-11:50	Gallbladder drainage: transpapillary and transmural drainage	Woo Hyun Paik (Seoul)
11:50-12:00	Q&As

Free Paper (PB 2) (Korean & English)
Nov. 16 (Fri) 10:30-12:00	KDDW Free Paper (PB 02)	E3 (3F)
Chairperson(s)	Tae Nyeun Kim (Daegu), Young Deok Cho (Seoul)
10:30-10:40	Differences in clinical features and outcomes of hypertriglyceridemia induced acute pancreatitis from the prospective acute pancreatitis registry of 558 patients.	So Jeong Kim (Incheon)
10:40-10:50	Acute pancreatitis in pregnant women. Features of diagnosis and treatment tactics	Nurmurod Ne'mat O'g'li Esanov (Tashkent)
10:50-11:00	Risk factors and outcomes of deep vein thrombosis in patients with necrotizing pancreatitis	Du-Jiang Yang (Chengdu)
Chairperson(s)	Hong Sik Lee (Seoul), Byung Moo Yoo (Suwon)
11:00-11:10	Comparison between groove pancreatitis and groove pancreatitis with extensive chronic pancreatitis	Jae Hyuck Jun (Daejeon)
11:10-11:20	Comparison of clinical outcomes between plastic stent and lumen-apposing metal stent for endoscopic ultrasound-guided drainage of peripancreatic fluid collections: A retrospective single centre experience	Chang Min Cho (Daegu)
11:20-11:30	Efficacy of intramuscular diclofenac in the prevention of post-ERCP pancreatitis: A prospective, randomized, placebo-controlled study	Byung Sam Park (Daegu)

Free Paper (GI Cancer 2) (Korean & English)
Nov. 16 (Fri) 10:30-12:00	KDDW Free Paper (GI Cancer 02)	E4 (3F)
Chairperson(s)	Yun Jeong Lim (Goyang), Bora Keum (Seoul)
10:30-10:40	Changing trends of colonoscopic burden: A nationwide population-based study in Korea	Jae Myung Cha (Seoul)
10:40-10:50	Risk of developing colorectal cancer based on the prior screening behaviors: Population-based cohort study.	Su Young Kim (Wonju)
10:50-11:00	Colorectal cancer screening among cancer survivors in the US	Adeyinka O Laiyemo (Washington)
11:00-11:10	Metabolically healthy obesity is associated with an increased risk of colorectal neoplasia recurrence	Hyun Beom Chae (Seoul)
11:10-11:20	Association between low relative muscle mass and the risk of colorectal neoplasia recurrence in Korean men and women	Kyung Mo Yoo (Seoul)
Chairperson(s)	Jin-Hyeok Hwang (Seongnam), Jae Hee Cho (Incheon)
11:20-11:30	Neoadjuvant FOLFIRINOX in patients with locally advanced pancreatic cancer	Young Hoon Choi (Seoul)
11:30-11:40	Lymphocyte-to-monocyte ratio is a valuable marker for predicting survival in patients with gallbladder cancer undergoing chemotherapy compared to neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio	Young Hoon Choi (Seoul)
11:40-11:50	Clinicopathologic characteristics and kras molecular alterations of adenosquamous carcinoma of the pancreas compared to pancreatic ductal adenocarcinoma	Sun Mi Lee (Jeju)
11:50-12:00	Detection of circulating tumor DNA and its application in pancreatic cancer patients	Joo Kyung Park (Seoul)

Okuda Lectureship
Nov. 16 (Fri) 11:00-11:30	Okuda Lectureship	Auditorium (3F)
Chairperson(s)	Rakesh Aggarwal (Lucknow), Yungsang Lee (Seoul)
11:00-11:30	Challenges of hepatitis B in the era of antiviral therapy	Henry LY Chan (Hong Kong)

Topic Forum (LG) (Korean)
Nov. 16 (Fri) 11:10-12:00	Topic Forum (LG)	E5 (3F)
Chairperson(s)	Hiun Suk Chae (Uijeongbu), Young-Eun Joo (Gwangju)
11:10-11:20	Risk factors including fecal markers for hospitalization in patients with ulcerative colitis	Byung Jin Kwon (Yangsan)
11:20-11:30	Mucosal healing is associated with transmural healing after 1-year treatment with anti-TNF agents in pediatric Crohn's disease patients	Ben Kang (Daegu)
11:30-11:40	Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on adalimumab maintenance therapy	Eun Hye Oh (Seoul)
11:40-12:00	Keynote Lecuture: Evolving monitoring for IBD patient care in clinical practice	Byung Ik Jang (Daegu)

Marshall & Warren Lectureship
Nov. 16 (Fri) 11:30-12:00	Marshall & Warren Lectureship	Auditorium (3F)
Chairperson(s)	Ian Roberts-Thomson (Hawthorn), Hyun Chae Jung (Seoul)
11:30-12:00	Chemoprevention of gastric cancer by H. pylori eradication and its underlying mechanism	Nayoung Kim (Seongnam)

Live Demonstration 1
Nov. 16 (Fri) 14:00-15:30	Live Demonstration 1	Auditorium (3F)
Chairperson(s)	Chan Sup Shim (Seoul), Christopher Jen Lock Khor (Singapore), James Lau (Hong Kong)
14:00-15:30	LGI	Hiroshi Kashida
14:00-15:30	PB	Seungmin Bang
14:00-15:30	PB	Se Woo Park

Symposium GI-02 (UG)
Nov. 16 (Fri) 14:00-15:30	Gastric carcinogenesis: Host, microbiome, and their interactions	101 (1F)
Chairperson(s)	Kwong Ming Fock (Singapore), Ki Baik Hahm (Seongnam)
14:00-14:20	Identification of genetic susceptibility for gastric cancer through genome-wide association studies	Benjamin Wong (Hong Kong)
14:20-14:40	Non-coding RNA and gastric cancer	Sang Kil Lee (Seoul)
14:40-15:00	Interactions between human and Helicobacter pylori in gastric carcinogenesis	Richard Peek (Nashville)
15:00-15:20	Non-Helicobacter pylori microbiome in gastric carcinogenesis	Yoshio Yamaoka (Yufu)
15:20-15:30	Q&As

Symposium EN-04 (UG)
Nov. 16 (Fri) 14:00-15:30	Recent advances of EUS: one more step	102 (1F)
Chairperson(s)	Laurent Palazzo (Paris), Dong-Wan Seo (Seoul)
14:00-14:20	Enhanced EUS imaging: Elastography and contrast enhanced EUS	Laurent Palazzo (Paris)
14:20-14:40	EUS-FNA/FNB in the UGI tract: when and how?	Rungsun Rerknimitr (Bangkok)
14:40-15:00	Present status of EUS in pancreatic cystic lesions	Yousuke Nakai (Tokyo)
15:00-15:20	Interpretation of EUS-FNA/FNB specimen: Pathologist’s view	Keetaek Jang (Seoul)
15:20-15:30	Q&As

Symposium LV-02
Nov. 16 (Fri) 14:00-15:30	Chronic hepatitis B: future treatment for the cure	103 (1F)
Chairperson(s)	Seung Woon Paik (Seoul), Shiv Kumar Sarin (New Delhi)
14:00-14:20	Potential therapeutic target in hepatitis B virus life cycle	Jia-Horng Kao (Taipei)
14:20-14:40	Current strategies to maximize HBsAg loss in patients with CHB	Pietro Lampertico (Milan)
14:40-15:00	Immunologic modulation for hepatitis B treatment	Antonio Bertoletti (Singapore)
15:00-15:20	Emerging drugs?& new therapeutic perspectives?for HBV	Henry LY Chan (Hong Kong)
15:20-15:30	Q&As

Symposium PB-02
Nov. 16 (Fri) 14:00-15:30	Cutting edge of pancreatic diseases	104 (1F)
Chairperson(s)	Chengwei Tang (Chengdu), Hsiu-Po Wang (Taipei)
14:00-14:20	Updates on the management of severe acute pancreatitis	Chengwei Tang (Chengdu)
14:20-14:40	Pancreatic enzyme replacement therapy in chronic pancreatitis	Hong Sik Lee (Seoul)
14:40-15:00	Updates on Ig G4 related diseases	Kazuichi Okazaki (Hirakata)
15:00-15:20	Current status of pancreatic cystic neoplasm management	Aiming Yang (Beijing)
15:20-15:30	Q&As

Combined-01 (Liver, PB)
Nov. 16 (Fri) 14:00-15:30	Autoimmune diseases of the liver and biliary system: the essentials	105 (1F)
Chairperson(s)	Myung-Hwan Kim (Seoul), Sook-Hyang Jeong (Seongnam)
14:00-14:20	Autoimmune hepatitis - 2018 Update	Atsushi Tanaka (Tokyo)
14:20-14:40	Primary biliary cholangitis: from diagnosis to treatment	Kyung-Ah Kim (Goyang)
14:40-15:00	Primary sclerosing cholangitis: what is the best management in the 21stcentury?	Hiroyuki Isayama (Tokyo)
15:00-15:20	IgG4-related sclerosing cholangitis: when to suspect, how to diagnose, and how to treat	Taejun Song (Seoul)
15:20-15:30	Q&As

Symposium GI-03 (LG)
Nov. 16 (Fri) 14:00-15:30	Shifting paradigm in IBD management	202 (2F)
Chairperson(s)	Joo Sung Kim (Seoul), Siew Chien Ng (Hong Kong)
14:00-14:20	New drugs on the horizon: Targeting cytokines, cell trafficking, and more	Choon Jin Ooi (Singapore)
14:20-14:40	Fecal microbiota transplantation for IBD: Ready to use?	Siew Chien Ng (Hong Kong)
14:40-15:00	Toward improving quality of care in IBD management	David Todd Rubin (Chicago)
15:00-15:20	Things you should know when managing elderly IBD patients	Jae Hee Cheon (Seoul)
15:20-15:30	Q&As

Symposium EN-05 (UG)
Nov. 16 (Fri) 14:00-15:30	Current status and future direction for early esophageal cancer treatment strategy	203 (2F)
Chairperson(s)	Joo Young Cho (Seongnam), Tsuneo Oyama (Saku)
14:00-14:20	High magnification and NBI imaging endoscopy for early esophageal cancer	Gwang Ha Kim (Busan)
14:20-14:40	ESD with multimodal treatment for esophageal cancer	Tsuneo Oyama (Saku)
14:40-15:00	Ablation therapy for esophageal cancer: when and how?	Jeong Hoon Lee (Seoul)
15:00-15:20	Management of esophageal stricture after endoscopic treatment	Yang Won Min (Seoul)
15:20-15:30	Q&As

APDW 2018 Plenary Oral 1
Nov. 16 (Fri) 14:00-15:30	Plenary Oral 1	205A (2F)
Chairperson(s)	Jidong Jia (Beijing), Dong Ki Lee (Seoul)
14:00-14:10	EUS-guided gastrojejunostomy using a lumen apposing metal stent in patients with symptomatic gastric outlet obstruction	Adeel Urrehman (Karachi)
14:10-14:20	Higher peak dose rather than prolonged duration of corticosteroid increases the risk of hepatitis flare in patients with chronic hepatitis B	Becky Wing-Yan Yuen (Shatin)
14:20-14:30	Roux en Y gastric bypass is associated with better short term cardiovascular risk reduction than sleeve gastrectomy in a multi-ethnic cohort	Baldwin Po Man Yeung (Singapore)
14:30-14:40	Incidence and risk factors for alcohol relapse after liver transplantation for alcoholic liver disease.	Dong Hyun Sinn (Seoul)
14:40-14:50	New staining method using antibody of methionyl-tRNA synthetase for brushing cytology can differentiate indeterminate bile duct strictures.	Sung Ill Jang (Seoul)
14:50-15:00	Is the new T1 category defined by the 8th edition AJCC pancreatic cancer staging system an improvement? An evaluation by multinational data	Wooil Kwon (Seoul)
15:10-15:20	PCSK9 inhibits HCC cell malignant biological behavior via binding to GSTP1	Mingyan He (Nanchang)

E-poster Presentations-05 (UG)
Nov. 16 (Fri) 14:00-15:30	H. pylori	R1A (3F)
Chairperson(s)	Jung Mogg Kim (Seoul), Khien Van Vu (Hanoi)
14:00-14:06	Prevalence of helicobacter pylori in eastern province Mongolia	Munkhtur Dandar (Choibalsan)
14:06-14:12	The role of migration inhibitory factor (MIF) in H. pylori infection and gastric cancer development	Chun-Sheng Shen (Kaohsiung)
14:12-14:18	Management of antibiotics-resistant helicobacter pylori infection -Perspectives from Vietnam	Khien Van Vu (Hanoi City)
14:18-14:24	Risk of overall mortality after helicobacter pylori treatment in patients with hypertension	Young-Il Kim (Goyang)
14:24-14:30	Efficacies of genotypic resistance-guided vs empirical therapy for refractory helicobacter pylori infection- A randomized controlled trial	Jyh-Ming Liou (Taipei)
14:30-14:36	Discriminating subjects with past helicobacter pylori infection among seronegative and unimpaired gastric secretory ability.	Hyungyung Kwon (Seoul)
14:36-14:42	Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria	Ping-I Hsu (Kaohsiung)
14:42-14:48	Modified amoxicillin triple therapy vs standard triple therapy for eradication of helicobacter pylori infection: A randomized control trial	Dennis Franco Fernandez (Manila)
14:48-14:54	The microbiota regulates bone marrow-derived mesenchymal stem cells in gastrointestinal cancer	Huiying Shi (Wuhan)
14:54-15:00	Association of helicobacter pylori infection with fatty liver infiltration in dyspeptic patients	Basit Siddiqui (Karachi)
15:00-15:06	Online registry for nationwide database of current trend of helicobacter pylori eradication in Korea: correlation of the density of antibiotics usage with eradication success	Beom Jin Kim (Seoul)
15:06-15:12	14-day bismuth high dose dual therapy is a robust second-line rescue therapy of H.pylori infection	Alex Hwong-Ruey Leow (Kuala Lumpur)

E-poster Presentations-06 (LG)
Nov. 16 (Fri) 14:00-15:30	Inflammatory bowel disease (2)	R1C (3F)
Chairperson(s)	Young Sook Park (Seoul), Zhihua Ran (Shanghai)
14:00-14:06	Efficacy of cumulative corticosteroid dose before the treatment with biologics on the outcome of UC patients: A retrospective multicenter experience	Yoshitaka Ueno (Hirosima)
14:06-14:12	Clinical significance of granulomas in Crohn`s disease: A meta-analysis	Seung Wook Hong (Seongnam)
14:12-14:18	Dose medical acceleration improve outcomes in ulcerative colitis patients who are in clinical remission but have endoscopic inflammation?	Ji Young Chang (Seoul)
14:18-14:24	Increased risk of end-stage renal disease in metabolically healthy patients with Crohn's disease : A nationwide population-based study	Seona Park (Seoul)
14:24-14:30	Increased risk of parkinson's disease in young patients with Crohn's disease: a nationwide population-based study	Seona Park (Seoul)
14:30-14:36	Increased risk of diabetes in inflammatory bowel disease: A nationwide population-based study in Korea	Eun Ae Kang (Seoul)
14:36-14:42	Increased risk of anxiety and depressive disorders associated with inflammatory bowel disease: a nationwide population-based study	Jaeyoung Chun (Seoul)
14:42-14:48	High-sensitivity C-reactive protein/albumin ratio are associated with disease activity of inflammatory bowel disease	Ailing Liu (Beijing)
14:48-14:54	Characteristics of extra-intestinal manifestations (EIM) in a local cohort of patients with inflammatory bowel disease (IBD)	Huiyu Lin (Singapore)
14:54-15:00	Microbial signature associated with prognosis of Crohns disease	Dong Il Park (Seoul)
15:00-15:06	A comparative study of infusion reactions associated with infliximab, vedolizumab and ustekinumab: Experience from a tertiary hospital in Singapore.	Andrew Xia Huang Tan (Singapore)
15:06-15:12	Low intestinal alkaline phosphatase ratio may predict clinical recurrence in patients with Crohn disease	Seon-Young Park (Gwangju)
15:12-15:18	Development of machine learning model to predict the prognosis in patients with inflammatory bowel disease (IBD)	Youni Choi (Inchoen)
15:18-15:24	Prevalence and associated factors of anemia in Taiwanese inflammatory bowel disease patients	Yew Loong Leong (Taipei)
15:24-15:30	Post-hoc analysis from the Phase 2 FITZROY study with the selective JAK1 inhibitor filgotinib: effect of disease duration and location on clinical remission in Crohns disease patients	Wai Keung Leung (Hong Kong)

E-poster Presentations-07 (LV)
Nov. 16 (Fri) 14:00-15:30	Alcoholic and nonalcoholic liver disease	R2A (3F)
Chairperson(s)	Manoj Kumar Sharma (New Delhi), Sungjin Hong (Shanghai)
14:00-14:06	Protocatechuic acid-mediated Sirtuin3 activation promotes fatty acid metabolism in non-alcoholic fatty liver disease	Jihong Yao (Dalian)
14:06-14:12	Effectiveness of probiotics in improving minimal hepatic encephalopathy in patients with compensated liver cirrhosis a meta-analysis	Higinio Mappala (Manila)
14:12-14:18	Antioxidants in patients with alcoholic liver disease	Le Thi Thu Hien (Thai Nguyen)
14:18-14:24	Relationship between cytokines and alcoholic liver disease	Le Thi Thu Hien (Thai Nguyen)
14:24-14:30	Severity of non-alcoholic fatty liver disease in Hong Kong and Australia	Nicole Phoebe Tanner (North Point)
14:30-14:36	Alcoholic fatty liver disease among unsafe drinkers: A prospective, community cohort, 7-year follow-up study	Madunil Anuk Niriella (Ragama)
14:36-14:42	Lifestyle Intervention enabled by mobile technologies leading to weight loss in patients with non-alcoholic fatty liver disease: a randomized controlled trial	Su Lin Lim (Singapore)
14:42-14:48	5% weight loss induces NAFLD fibrosis as defined through interval elastography - Preliminary data from a single tertiary hospital in Singapore	Wei De Tee (Singapore)

E-poster Presentations-08 (Surgery)
Nov. 16 (Fri) 14:00-15:30	Surgery: Upper GI, lower GI, others	R2C (3F)
Chairperson(s)	Kyo Young Song (Seoul), Kent-Man Chu (Hong Kong)
14:00-14:06	Body mass index and mortality in patients with gastric cancer: A large cohort study	Jung Hwan Lee (Incheon)
14:06-14:12	Tranalation and valiadation of eortc qlq-cr29 quality of life questionnaire (sinhala version)	Dakshitha Wickramasinghe (Colombo)
14:12-14:18	Enhanced recovery after colorectal surgery (ERAS) protocol in Sri Lanka an assessment of current practice of colorectal surgery among general surgical units in a developing country in south Asia	Chamila Lakmal (Colombo)
14:18-14:24	Non-exposure simple suturing endoscopic full-thickness resection (NESS-EFTR) with sentinel basin dissection in patients with early gastric cancer	Bang Wool Eom (Goyang)
14:24-14:30	Survival outcomes of local excision versus radical resection for early colorectal cancer in young patients: A propensity matching study	Bin Cao (Beijing)
14:30-14:36	Treatment strategy of intraperitoneal and systemic chemotherapy combined with gastrectomy for gastric cancer with peritoneal metastasis	Daisuke Kobayashi (Nagoya)
14:36-14:42	A single institution experience of laparoscopic gastrectomy in advanced gastric cancer: analysis of postoperative morbidities and long-term oncologic outcomes	Sa-Hong Min (Seongnam)
14:42-14:48	Risk factor and treatments of chylothorax after esophageal cancer surgery	Moyuru Yamada (Toyonakacity)
14:48-14:54	A single center experience of 50 fundoplications in Hong Kong	Ho Kiu Grace Wong (Hong Kong)

Symposium GI-04 (GI Cancer)
Nov. 16 (Fri) 14:00-15:30	Gastirc cancer, are we in new era for management?	E1+2 (3F)
Chairperson(s)	Hyunyong Jeong (Daejeon), James R. Goldenring (Nashville)
14:00-14:20	The global change in epidemiology of gastric cancer	Jin Young Park (Lyon)
14:20-14:40	Role of?SPEM in gastric carcinogenesis	James R. Goldenring (Nashville)
14:40-15:00	Do we have proper surgical modalities to preserve functional aspect after gastric cancer surgery?	Keun Won Ryu (Goyang)
15:00-15:20	Current treatment landscape and future perspectives in patients with advanced gastric cancer	Sung Eun Kim (Busan)
15:20-15:30	Q&As

Free Paper (PB 3) (Korean)
Nov. 16 (Fri) 14:00-15:30	KDDW Free Paper (PB 03)	E3 (3F)
Chairperson(s)	Jaeseon Kim (Seoul), Seon Mee Park (Cheongju)
14:00-14:10	Acalculous cholecystitis in burn intensive care unit patients: Incidence and predisposing factors	Hoongoo Lee (Hwaseong)
14:10-14:20	Clinical characteristics of colonic adenoma according to characteristics of gallstones	Jaehyun Tae (Seoul)
14:20-14:30	Chronological changes of epidemiologic characteristics of gallstone over last 20years in Korean single large volume center	Jiyong Zhao (Seoul)
14:30-14:40	Incidence and risk factors for gallstone formation after surgical and endoscopic therapy	Soyeong Kim (Daegu)
Chairperson(s)	Jin Lee (Hwasung), Jong Hyeok Kim (Anyang)
14:40-14:50	Incidence of cholelithiasis in patients with inflammatory bowel disease	Sooyeong Kwak (Daegu)
14:50-15:00	Biliary tuberculosis impersonating as cholangiocarcinoma: Single- center experiences	Jae Hyuck Jun (Daejeon)
15:00-15:10	Outcomes of endoscopic papillary large balloon dilation for bile duct stones: Before and after international consensus guideline	Dae Jung Kim (Suwon)

KDDW Free Paper (LG 3) (Korean)
Nov. 16 (Fri) 14:00-15:30	KDDW Free Paper (LG 3)	E5 (3F)
Chairperson(s)	Kooklae Lee (Seoul), Soon Man Yoon (Cheongju)
14:00-14:10	Cost drivers for inflammatory bowel disease care: a population-based study using the korean national health insurance claims data (2006-2015)	Jung-Wook Kim (Seoul)
14:10-14:20	Real life effectiveness and safety of vedolizumab as induction therapy for Korean IBD patients in whom anti-TNF treatment failed: A prospective cohort study	Jeongseok Kim (Seoul)
14:20-14:30	Influence of Vitamin D status on the clinical course of ulcerative colitis	Nam Seok Ham (Seoul)
Chairperson(s)	Moon Sung Lee (Bucheon), Bo-In Lee (Seoul)
14:30-14:40	Impact of family history of colorectal cancer on age-specific prevalence of colorectal	Seulki Kim (Seoul)
14:40-14:50	The association of cigarette smoking and alcohol consumption with sessile serrated adenoma in 30-49 year-old subjects	Ji Young Lee (Seoul)
14:50-15:00	prevalence of and risk factors for colorectal neoplasia in asymptomatic young adults aged 20 to 39 years	Jin Ju Song (Seoul)
15:00-15:10	Does colon diverticulosis raise the risk of adenomatous colon polyp in patients with colorectal cancer?	Suyun Oh (Suwon)

WEO Honorary Lecture
Nov. 16 (Fri) 16:00-17:00	WEO Honorary Lectureship	104 (1F)
Chairperson(s)	Jean-Francois Rey (Saint Laurent Du Var)
16:00-16:50	Paving the way to the globalization of advanced endoscopy	Hisao Tajiri (Tokyo)
16:50-17:00	Q&A

Live Demonstration 2
Nov. 16 (Fri) 16:00-17:30	Live Demonstration 2	Auditorium (3F)
Chairperson(s)	Dong Ki Lee (Seoul), Shutian Zhang (Beijing), Mahesh Kumar Goenka (Kolkata)
16:00-17:30	UGI, PB	Enqiang Linghu
16:00-17:30	UGI	Jun Chul Park

Symposium GI-05 (LG)
Nov. 16 (Fri) 16:00-17:30	The cutting edge issues in management of IBD 2018	102 (1F)
Chairperson(s)	Suk-Kyun Yang (Seoul), Jiaming Qian (Beijing)
16:00-16:20	What should be the therapeutic targets in IBD therapy?	Siew Chien Ng (Hong Kong)
16:20-16:40	Proper positioning of various drugs in therapeutic algorithm	Won Moon (Busan)
16:40-17:00	Place of TDM in optimal use of biologics	Akira Andoh (Otsu)
17:00-17:20	Managing Crohn's disease after surgery	Kang-Moon Lee (Suwon)
17:20-17:30	Q&As

Symposium LV-03
Nov. 16 (Fri) 16:00-17:30	Chronic hepatitis C in DAA era	103 (1F)
Chairperson(s)	Kwan Soo Byun (Seoul), Rakesh Aggarwal (Lucknow)
16:00-16:20	HCV screening in general population: is this cost-effective in DAA era?	Rakesh Aggarwal (Lucknow)
16:20-16:40	Is there difficult to treat population in HCV patients in DAA era?	Naoya Sakamoto (Sapporo)
16:40-17:00	Increased risk of HCC following DAA: fact or fiction?/Follow up strategy after SVR in chronic hepatitis C	Yasuhiro Asahina (Tokyo)
17:00-17:20	DAA first versus transplantation first in decompensated cirrhotic HCV patients	Young-Suk Lim (Seoul)
17:20-17:30	Q&As

Combined-02 (Endoscopy-Surgery)
Nov. 16 (Fri) 16:00-17:30	Gastrointestinal diseases and treatments in obese patients (KSGE combined session)	105 (1F)
Chairperson(s)	Sung Kwan Shin (Seoul), Joo Ho Lee (Seoul)
16:00-16:20	Functional gastrointestinal disorders in obese patients	Yong Sung Kim (Iksan)
16:20-16:40	Gastrointestinal tumors associated with obesity	Jin-Hyeok Hwang (Seongnam)
16:40-17:00	Endoscopic treatments for morbid obesity	Hyuk Soon Choi (Seoul)
17:00-17:20	Surgical treatments for morbid obesity	Takeshi Naitoh (Sendai)
17:20-17:30	Q&As

Symposium GI-06 (UG)
Nov. 16 (Fri) 16:00-17:30	All about GIST on UGI tract	202 (2F)
Chairperson(s)	Chang-Hun Yang (Gyeongju), Byung-Wook Kim (Incheon)
16:00-16:20	Pathologic diagnosis; focused on prognostic factor	Gu Hyun Kang (Seoul)
16:20-16:40	Endoscopic treatment: when and how?	Hanglak Lee (Seoul)
16:40-17:00	Surgical treatment: when and how?	Hyundong Chae (Daegu)
17:00-17:20	Target therapy: when and how?	Dong-Hoe Koo (Seoul)
17:20-17:30	Q&As

Symposium PB-03
Nov. 16 (Fri) 16:00-17:30	Recent advances in intra- and extrahepatic cholangiocarcinoma: promising or practice changing?	203 (2F)
Chairperson(s)	Ho Soon Choi (Seoul), Ji Kon Ryu (Seoul), Dong Sup Yoon (Seoul)
17:20-17:30		Dong Hee Koh (Hwaseong)
16:00-16:20	Pathogenesis and molecular characterization: from genetics to signaling pathways	Young Nyun Park (Seoul)
16:20-16:40	Pathologic classification: new concepts	Kyoungbun Lee (Seoul)
16:40-17:00	Endoscopic management: from ERCP to EUS	Masayuki Kitano (Wakayama)
17:00-17:20	Selection of patients for curative resection and role of surgery: from resection to transplantation	Masayuki Ohtsuka (Chiba)

APDW 2018 Plenary Oral 2
Nov. 16 (Fri) 16:00-17:30	Plenary Oral 2	205A (2F)
Chairperson(s)	Kent-Man Chu (Hong Kong), Ming-Shiang Wu (Taipei)
16:00-16:10	The relationship between enterobacterial flora and prognosis in patient with ulcerative colitis	Tomoya Sugiyama (Nagakute)
16:10-16:20	Analysis of key genes and signaling pathways involved in helicobacter pylori-associated gastric cancer based on the cancer genome atlas database and RNA-sequencing	Yi Hu (Nanchang)
16:20-16:30	Features of post-colonoscopy colorectal cancer and survival times of patients in Korea	Jae Myung Cha (Seoul)
16:30-16:40	An open-label, multicenter, randomized controlled trial of vonoprazan versus esomeprazole as part of first-line triple therapy for helicobacter pylori infection	Hiroyuki Tamaki (Takamatsu)
16:40-16:50	Evolving the novel per oral endoscopic myotomy and fundoplication (POEM+F) procedure: Application of endoscopic hand-suturing technique	Akiko Ueno (Tokyo)
16:50-17:00	POEM is more effective than balloon dilation in all achalasia subtypes: based on data from a single tertiary referral center	Ga Hee Kim (Seoul)
17:00-17:10	Simple liquid arrays of three aptamers are valuable for the diagnosis of gastric cancer	Yuting He (Nanchang)
17:10-17:20	Deep learning versus simple clinical scores for prediction of advanced neoplasia in colorectal cancer screening	Hyo-Joon Yang (Seoul)
17:20-17:30	gut microbiota from patients with colorectal cancer promotes the progression of intestinal adenoma in apcmin/+ mice	Hai-Long Cao (Tianjin)

E-poster Presentations-09 (UG, Motility)
Nov. 16 (Fri) 16:00-17:30	H. pylori, other upper GI disorders	R1A (3F)
Chairperson(s)	Jae Myung Park (Seoul), Amit Kumar Dutta (Vellore)
16:00-16:06	The study of motor and evacuation functions of the stomach and rectum in patients with functional dyspepsia and irritable bowel syndrome	Oybek Otabekovich Usmonov (Tashkent)
16:06-16:12	Objective and subjective approaches in the treatment of patients with GERD with a syndrome of vegetative dystonia	Oybek Otabek O'g'li Usmonov (Tashkent)
16:12-16:18	Duodenal eosinophil and mast cell count and its relation with functional dyspepsia; A case control study	Madhusudan Saha (Sylhet)
16:18-16:24	Efficacy of endoscopic therapeutic procedures in non variceal upper gastrointestinal bleeding in hanoi medical university hospital from 2013 to 2017	Hang Dao (Hanoi)
16:24-16:30	The association between electronic cigarette smoking and dyspepsia in adult urban population	Ahmad Fariz Malvi Zamzam Zein (Cirebon)
16:30-15:36	Current risk factors for peptic ulcer disease in the background of declining frequency of helicobacter pylori infection in patients with dyspepsia	Amit Kumar Dutta (Vellore)
16:36-16:42	Impact of upper gastrointestinal symptoms on quality of life in type 2 diabetes patients: preliminary study in Banten province hospital, Indonesia	Laras Budiyani (Serang)
16:42-16:48	Systematic review and meta-analysis: prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome	Ayesha Shah (Brisbane)
16:48-16:54	The association between peptic ulcer disease and osteoporosis: A 12-year follow up of the Korean genome and epidemiology study	Kanglok Lee (Incheon)
16:54-17:00	H. pylori genotyping and genomic diversity assessment ingastric biopsies from residents of high altitude ( ladakh ) and lower plains of north India	Nisha Sharma (Delhi)
17:00-17:06	Cost-effectiveness of a tailored helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients	Seri Ryu (Seoul)

E-poster Presentations-10 (LG)
Nov. 16 (Fri) 16:00-17:30	Inflammatory bowel disease (3)	R1C (3F)
Chairperson(s)	Jae Hee Cheon (Seoul), Vineet Ahuja (New Delhi)
16:00-16:06	The COX-2/PGE2 pathway is central for efficacy of TNF inhibitors and intestinal epithelial regeneration in ulcerative colitis	Ole Haagen Nielsen (Herlev)
16:06-16:12	Using anaemia as an isolated marker to predict the extent of inflammatory bowel disease at diagnosis	Hang Hoi Michael Wong (Hong Kong)
16:12-16:18	Predictors of using traditional medicine, complementary and alternative medicine in inflammatory bowel disease in Hong Kong: the first patients self report in ethnic Chinese	Jessica Y L Ching (Hong Kong)
16:18-16:24	Age at onset, maintenance therapy and erythrocyte sedimentation rate are independent risk factors for anal fistula in Crohns disease	Guanghui Lian (Changsha)
16:24-16:30	Disease activity and severity of ulcerative colitis are associated with increased mucosal candida colonization and Beta-D-Glucan levels	Jimil Hiteshbhai Shah (Chandigarh)
16:30-15:36	Incidence and outcomes of acute severe ulcerative colitis (ASUC) - A retrospective cohort study in a Singapore tertiary institution	Kaina Chen (Singapore)
16:36-16:42	Molecular detection of pathogenic gut bacteria in inflammatory bowel disease (IBD) patients is not influenced by disease activity	Deborah Chia Hsin Chew (Malaysia)
16:42-16:48	Trends in inflammatory bowel disease incidence in Korea: A nationwide population-based study 2004-2015	Jae Jun Park (Seoul)
16:48-16:54	Study of predictive factors and clinical implication of deep mucosal healing in ulcerative colitis	Deepak Gupta (Mumbai)
16:54-17:00	Natural history of inflammatory bowel disease from 1970 to 2017 - Results from a large single center in Singapore	Miao Shan Lim (Singapore)

E-poster Presentations-11 (LV)
Nov. 16 (Fri) 16:00-17:30	Autoimmune liver disease, cirrhosis	R2A (3F)
Chairperson(s)	Il Han Song (Cheonan), Kang Mo Kim (Seoul)
16:00-16:06	Fluorofenidone reveals a novel function for glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and hepatic fibrosis	Yu Peng (Changsha)
16:06-16:12	Rapid endoscopic ultrasound screening of hepatopulmonary syndrome (RUSH): a safe, simple and quick procedure for gastroenterologist	Rahul Pundlik Talele (Meerut)
16:12-16:18	Outcomes of large volume paracentesis in cirrhotic patients with spontaneous bacterial peritonitis.	Rabeea Azmat (Karachi)
16:18-16:24	PXR activation by ginkgolide a restores inflammation and tight junction integrity in cirrhosis	Balasubramaniyan Vairappan (Pondicherry)
16:24-16:30	Tofacitinib ameliorates inflammation effectively in immune-mediated hepatic injury	Han Wang (Wuhan)
16:30-15:36	The demographic, clinical features, response to treatment and outcome of autoimmune hepatitis (AIH) patients in multi-ethnic Malaysia since 2002	Yun Chien Chung (Batu Caves)
16:36-16:42	The distribution of non-tumoral portal vein thrombosis in liver cirrhosis and its relationship with wall shear stress	Zongfang Li (Xi'an)
16:42-16:48	A gravity-assisted liver stiffness measurement	Itsuo Nagayama (Minami Uonuma)
16:48-16:54	Repeated versus single treatment of esophageal variceal ligation after esophageal variceal bleeding: Multicenter retrospective study	Young Hwan Choi (Seoul)
16:54-17:00	Gastric vascular ectasia (GAVE) not rare cause of GI bleed in liver cirrhosis ; cross sectional study on factors associated with GAVE with or with out portal hypertensive gastropathy (PHG) in liver cirrhosis in tertiary care hospital Karachi Paksitan	Om Parkash (Karachi)

E-poster Presentations-12 (PB)
Nov. 16 (Fri) 16:00-17:30	Endoscopic retrograde cholangiopancreatography (ERCP)	R2C (3F)
Chairperson(s)	Sang-Woo Cha (Seoul), Ari Fahrial Syam (Depok)
16:00-16:06	Demonstrating competence in endoscopic retrograde cholangiopancreaticography (ERCP): recently credentialed operators performance for deep biliary cannulation over 1 year period from tertiary care hospital in Pakistan.	Om Parkash (Karachi)
16:06-16:12	A retrospective comparison of transpancreatic septotomy and needle knife sphincterotomy in difficult biliary cannulation	Cherng Harng Lim (Chanhua)
16:12-16:18	The usefulness of newly modified non-flared fully covered metal stent of 12 mm-diameter comparing with conventional stent for periampullary malignant biliary strictures	Jin Yong Lee (Bucheon)
16:18-16:24	Bile duct injury after laparoscopic cholecystectomy: new classification and novel approach for the management in emergency situations.	Chintan Patel (Surat)
16:24-16:30	Patterns of bile duct injuries observed during endoscopic retrograde cholangiogram: 13 years of experience in a tertiary care referral centre in south Asia	Chamila Lakmal (Colombo)
16:30-15:36	Endoscopic management of difficult biliary stones; utility of ERCP using short type double balloon endoscope in patients with surgically altered anatomy	Masaaki Shimatani (Osaka)
16:36-16:42	The sphincter-preserving effect of duodenal papilla occlusion by SureClip from MicroTech	Yonghui Huang (Beijing)
16:42-16:48	Clinical utility of endoscopic therapy for bile leak associated with posthepatobiliary surgery	Hideyuki Shiomi (Kobe)
16:48-16:54	A novel technique using loop-device for the repositioning of ENBD catheter in ERCP	Jae Min Lee (Seoul)
16:54-17:00	Efficacy of endoscopic plastic stents for anastomotic biliary strictures after right lobe adult living donor liver transplantation	Min Su You (Seoul)
17:00-17:06	Proper initial stent type for palliative bilateral biliary drainage for unresectable advanced malignant hilar obstruction	Young Hoon Choi (Seoul)
17:06-17:12	Risk of failure and complications of endoscopic retrograde cholangiopancreatography; comparison of elderly and young pakistani patients	Talal Khurshid (Islamabad)

PG Course-LG (Korean)
Nov. 16 (Fri) 16:00-17:30	Current status and future perspectives in management of small bowel diseases	E1+2 (3F)
Chairperson(s)	Hyun Soo Kim (Gwangju), Sung-Ae Jung (Seoul)
16:00-16:20	Optimal approach to small bowel bleeding	Hyun Jung Lee (Seoul)
16:20-16:40	Radiologic diagnosis of small bowel diseases	Jeong Kyong Lee (Seoul)
16:40-17:00	Therapeutic role of enteroscopy	Sung Noh Hong (Seoul)
17:00-17:20	Interesting cases of various small bowel diseases	Bong Min Ko (Bucheon)
17:20-17:30	Q&As

Free Paper (PB 4) (Korean)
Nov. 16 (Fri) 16:00-17:30	KDDW Free Paper (PB 04)	E3 (3F)
Chairperson(s)	Seong Woo Nam (Seoul), Young Koog Cheon (Seoul)
16:00-16:10	Antitumor effects of flavokawain B on cholangiocarcinoma	Young Hoon Choi (Seoul)
16:10-16:20	Carbohydrate antigen 19-9 as a prognostic marker of intrahepatic cholangiocarcinoma after surgical resection	Gunn Huh (Seoul)
16:20-16:30	Clinical relevance of BilIN in surgical margin of perihilar cholangiocarcinoma	Soong Goo Jung (Seoul)
Chairperson(s)	Young Soo Moon (Busan), Se-Joon Lee (Yongin)
16:30-16:40	Efficacy and safety of simultaneous side-by-side bilateral placement of braided-type metal stents using 6F-introducer for unresectable malignant hilar bile duct obstruction: A retrospective feasibility study	Doo Hyun Ko (Inchon)
16:40-16:50	Comparison of preoperative CT scan, EUS Findings, and Histopathologic Findings of Gallbladder Polyps Larger than 1 cm in Size	Jae Kook Yang (Cheonan)
16:50-17:00	Long-term outcomes of endoscopic papillectomy after an insulated plastic pancreatic stent placement	Sun Ung Youn (Suwon)

AGA-APAGE
Nov. 16 (Fri) 16:00-18:00	From bench to clinic in gastric cancer: Where are we headed?	101 (1F)
Chairperson(s)	Emad Munir El-Omar (Sydney), Sang Woo Lee (Ansan)
16:00-16:25	The molecular pathogenesis of gastric cancer ? state of the art	Timothy Cragin Wang (New York)
16:25-16:50	The role of the gastric microbiome in H. pylori-induced gastric cancer	Richard Peek (Nashville)
16:50-17:15	Prevention of gastric cancer ? opportunities and potential problems	Kentaro Sugano (Shimotsuke)
17:15-17:40	National gastric cancer screening- outcomes and future challenges	Il Ju Choi (Goyang)
17:40-18:00	Q&As